[1]Jung MC, Hartmann B, Gerlach JT, et al.Virus-specific lympho-kine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection[J].Virology, 1999, 261 (2) ∶165-172.
|
[2]Barnaba V, Franco A, Paroli M, et al.Selective expansion of cyto-toxic T lymphocytes with a CD4+CD56+surface phenotype and a T helper type1profile of cytokine secretion in The liver of patients chronically infected with Hepatitis B virus[J].J Immunol, 1994, 15 (6) ∶3074-3087.
|
[3]Raffaele C, Nicoletta V, Emanuela B, et al.Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates[J].Antivir ResVolume Issue, 1994, 23 (1) ∶77-89.
|
[4]Stoop JN, van der Molen RG., Baan CC, et al.Regulatory T cells contribute to The impaired immune response in patients with chronic hepatitis B virus infection[J].Hepatology, 2005, 41 (4) ∶771-778.
|
[5]EiriniI R, Deepak S, Shilpa C et al.Lamivudine Plus Interleukin-12Combination Therapy in Chronic Hepatitis B:Antiviral and Immuno-logicalActivity[J].Hepatology, 2005, 42 (5) ∶1028-36.
|
[6]江军, 缪晓辉, 蔡雄.阿德福韦酯和拉米夫定对慢性乙型肝炎患者IFN-γ和IL-4的影响比较[J].临床肝胆病杂志.2007, 23 (3) ∶176-178.
|
[7]马萍, 王磊, 王怡, 等.慢性乙型肝炎患者阿德福韦酯治疗前后血清Th1和Th2细胞因子水平变化及其与HBeAg的关系[J].中华实验和临床感染病杂志 (电子版) , 2008, 2 (1) ∶55-58.
|
[8]Jiang YF, Wang F, Liu YY, et al.The host immunity response of hepatitis B patients after Adefovir dipivoxil and Entecavir therapy[J].Hepatology, 2008, 47 (6) ∶1020.
|
[9]Kuo TM, Hu CP, Chen YL, et al.HBV replication is significantly reduced by IL-6[J].Journal of Biomedical Science, 2009, 16 (1) ∶41.
|